Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy

Epilepsy and Behavior

Volumn 14, Issue 1, 2009, Pages 27-31

  Taha, Ameer Y ^a   Ciobanu, Flaviu A ^a   Saxena, Anjali ^a   McIntyre Burnham, W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Arrhythmias; Cardiac arrest; Docosahexaenoic acid; Ischemia; Omega 3 polyunsaturated fatty acids; Sudden unexpected death in epilepsy

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PENTETRAZOLE;

ANTIARRHYTHMIC ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; EPILEPSY; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPOVENTILATION; NONHUMAN; REVIEW; RISK REDUCTION; SUDDEN DEATH;

ANIMALS; ANTICONVULSANTS; ARRHYTHMIAS, CARDIAC; CARDIOTONIC AGENTS; CONVULSANTS; DEATH, SUDDEN, CARDIAC; EPILEPSY; FATTY ACIDS, OMEGA-3; HEART ARREST; HUMANS; MYOCARDIAL ISCHEMIA; PENTYLENETETRAZOLE; SEIZURES;

EID: 58149163259     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.10.012     Document Type: Review

References (76)

1. Scorza F.A., Cysneiros R.M., Arida R.M., Terra-Bustamante V.C., de Albuquerque M., and Cavalheiro E.A. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav 13 (2008) 279-283
2. DeGiorgio C.M., and Miller P. n-3 fatty acids (eicosapentanoic and docosahexanoic acids) in epilepsy and for the prevention of sudden unexpected death in epilepsy. Epilepsy Behav 13 4 (2008) 712-713
3. Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 38 (1997) S9-S12
4. Carpio A., Bharucha N.E., Jallon P., et al. Mortality of epilepsy in developing countries. Epilepsia 46 Suppl. 11 (2005) 28-32
5. Diop A.G., Hesdorffer D.C., Logroscino G., and Hauser W.A. Epilepsy and mortality in Africa: a review of the literature. Epilepsia 46 Suppl. 11 (2005) 33-35
6. Hauser W.A., Annegers J.F., and Elveback L.R. Mortality in patients with epilepsy. Epilepsia 21 (1980) 399-412
7. Forsgren L., Hauser W.A., Olafsson E., Sander J.W., Sillanpaa M., and Tomson T. Mortality of epilepsy in developed countries: a review. Epilepsia 46 Suppl. 11 (2005) 18-27
8. Shackleton D.P., Westendorp R.G., Kasteleijn-Nolst Trenite D.G., de Craen A.J., and Vandenbroucke J.P. Survival of patients with epilepsy: an estimate of the mortality risk. Epilepsia 43 (2002) 445-450
9. Sperling M.R., Harris A., Nei M., Liporace J.D., and O'Connor M.J. Mortality after epilepsy surgery. Epilepsia 46 Suppl. 11 (2005) 49-53
10. Opeskin K., Harvey A.S., Cordner S.M., and Berkovic S.F. Sudden unexpected death in epilepsy in Victoria. J Clin Neurosci 7 (2000) 34-37
11. Kloster R., and Engelskjon T. Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors. J Neurol Neurosurg Psychiatry 67 (1999) 439-444
12. Racoosin J.A., Feeney J., Burkhart G., and Boehm G. Mortality in antiepileptic drug development programs. Neurology 56 (2001) 514-519
13. Tomson T., Walczak T., Sillanpaa M., and Sander J.W. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 46 Suppl. 11 (2005) 54-61
14. Hindocha N., Nashef L., Elmslie F., et al. Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. Epilepsia 49 (2008) 360-365
15. Nashef L., Hindocha N., and Makoff A. Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms. Epilepsia 48 (2007) 859-871
16. Stollberger C., and Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 59 (2004) 51-60
17. Leestma J.E., Walczak T., Hughes J.R., Kalelkar M.B., and Teas S.S. A prospective study on sudden unexpected death in epilepsy. Ann Neurol 26 (1989) 195-203
18. Walczak T.S., Leppik I.E., D'Amelio M., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56 (2001) 519-525
19. Langan Y., Nashef L., and Sander J.W. Case-control study of SUDEP. Neurology 64 (2005) 1131-1133
20. Nilsson L., Farahmand B.Y., Persson P.G., Thiblin I., and Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353 (1999) 888-893
21. Colugnati D.B., Arida R.M., Cravo S.L., et al. Hibernating mammals in sudden cardiac death in epilepsy: what do they tell us?. Med Hypoth 70 (2008) 929-932
22. Scorza F.A., Colugnati D.B., Pansani A.P., Sonoda E.Y., Arida R.M., and Cavalheiro E.A. Preventing tomorrow's sudden cardiac death in epilepsy today: what should physicians know about this?. Clinics 63 (2008) 389-394
23. Scorza F.A., Cysneiros R.M., Cavalheiro E.A., Arida R.M., and Gattaz W.F. Cold weather and risk of sudden cardiac death in schizophrenia: finding a new Achilles' heel?. Rev Bras Psiquiatr 30 (2008) 169-170
24. Yuen A.W., Thompson P.J., Flugel D., Bell G.S., and Sander J.W. Mortality and morbidity rates are increased in people with epilepsy: is stress part of the equation?. Epilepsy Behav 10 (2007) 1-7
25. George J.R., and Davis G.G. Comparison of anti-epileptic drug levels in different cases of sudden death. J Forens Sci 43 (1998) 598-603
26. Langan Y., Nashef L., and Sander J.W. Sudden unexpected death in epilepsy: a series of witnessed deaths. J Neurol Neurosurg Psychiatry 68 (2000) 211-213
27. Kandler L., Fiedler A., Scheer K., Wild F., Frick U., and Schneider P. Early postconvulsive prolongation of QT time in children. Acta Paediatr 94 (2005) 1243-1247
28. Opherk C., Coromilas J., and Hirsch L.J. Heart rate and EKG changes in 102 seizures: analysis of influencing factors. Epilepsy Res 52 (2002) 117-127
29. Nei M., Ho R.T., and Sperling M.R. EKG abnormalities during partial seizures in refractory epilepsy. Epilepsia 41 (2000) 542-548
30. Zijlmans M., Flanagan D., and Gotman J. Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia 43 (2002) 847-854
31. Nilsson L., Tomson T., Farahmand B.Y., Diwan V., and Persson P.G. Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia 38 (1997) 1062-1068
32. Cockerell O.C., Johnson A.L., Sander J.W., Hart Y.M., Goodridge D.M., and Shorvon S.D. Mortality from epilepsy: results from a prospective population-based study. Lancet 344 (1994) 918-921
33. Annegers J.F., Hauser W.A., and Shirts S.B. Heart disease mortality and morbidity in patients with epilepsy. Epilepsia 25 (1984) 699-704
34. Elliott J.O., Jacobson M.P., and Haneef Z. Cardiovascular risk factors and homocysteine in epilepsy. Epilepsy Res 76 (2007) 113-123
35. Falconer B., and Rajs J. Post-mortem findings of cardiac lesions in epileptics: a preliminary report. Forens Sci 8 (1976) 63-71
36. Natelson B.H., Suarez R.V., Terrence C.F., and Turizo R. Patients with epilepsy who die suddenly have cardiac disease. Arch Neurol 55 (1998) 857-860
37. Opeskin K., Thomas A., and Berkovic S.F. Does cardiac conduction pathology contribute to sudden unexpected death in epilepsy?. Epilepsy Res 40 (2000) 17-24
38. Johnston S.C., Horn J.K., Valente J., and Simon R.P. The role of hypoventilation in a sheep model of epileptic sudden death. Ann Neurol 37 (1995) 531-537
39. Johnston S.C., Siedenberg R., Min J.K., Jerome E.H., and Laxer K.D. Central apnea and acute cardiac ischemia in a sheep model of epileptic sudden death. Ann Neurol 42 (1997) 588-594
40. Krall R.L., Penry J.K., White B.G., Kupferberg H.J., and Swinyard E.A. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19 (1978) 409-428
41. Fisher R.S. Animal models of the epilepsies. Brain Res Brain Res Rev 14 (1989) 245-278
42. Taha A.Y., Huot P.S., Reza-Lopez S., et al. Seizure resistance in fat-1 transgenic mice endogenously synthesizing high levels of omega-3 polyunsaturated fatty acids. J Neurochem 105 (2008) 380-388
43. Taha A.Y., Baghiu B.M., Lui R., Nylen K., Ma D.W., and Burnham W.M. Lack of benefit of linoleic and alpha-linolenic polyunsaturated fatty acids on seizure latency, duration, severity or incidence in rats. Epilepsy Res 71 (2006) 40-46
44. Taha AY, Filo E, Ma DWL, Burnham WM. Dose-dependent anticonvulsant effects of linoleic and alpha-linolenic polyunsaturated fatty acids on pentylenetetrazol induced seizures in rats. Epilepsia; 2008. [Epub ahead of print].
45. Terndrup T.E., and Fordyce W.E. Respiratory drive during status epilepticus and its treatment: comparison of diazepam and lorazepam. Epilepsy Res 20 (1995) 21-30
46. Doba N., Beresford H.R., and Reis D.J. Changes in regional blood flow and cardiodynamics associated with electrically and chemically induced epilepsy in cat. Brain Res 90 (1975) 115-132
47. Kang J.X., Wang J., Wu L., and Kang Z.B. Transgenic mice. fat-1 mice convert n-6 to n-3 fatty acids. Nature 427 (2004) 504
48. Yuen A.W., and Sander J.W. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 13 (2004) 104-107
49. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
50. Mozaffarian D., Bryson C.L., Lemaitre R.N., Burke G.L., and Siscovick D.S. Fish intake and risk of incident heart failure. J Am Coll Cardiol 45 (2005) 2015-2021
51. Chan D.C., Watts G.F., Nguyen M.N., and Barrett P.H. Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am J Clin Nutr 84 (2006) 37-43
52. McKenney J.M., and Sica D. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy 27 (2007) 715-728
53. McKenney J.M., and Sica D. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm 64 (2007) 595-605
54. Tsitouras P.D., Gucciardo F., Salbe A.D., Heward C., and Harman S.M. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40 (2008) 199-205
55. Kabir M., Skurnik G., Naour N., et al. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86 (2007) 1670-1679
56. Krauss-Etschmann S., Hartl D., Rzehak P., et al. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-β levels after fish oil supplementation of pregnant women. J Allergy Clin Immunol 121 (2008) 464-470
57. + channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 92 (1995) 11000-11004
58. 2+, and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci USA 91 (1994) 8832-8836
59. + currents in adult ferret cardiomyocytes. Sheng Li Xue Bao 54 (2002) 271-281
60. + channel (Kv1.5) by polyunsaturated fatty acids. Proc Natl Acad Sci USA 91 (1994) 1937-1941
61. + channels by directly binding to the channel proteins. Proc Natl Acad Sci USA 93 (1996) 3542-3546
62. Kang J.X., Xiao Y.F., and Leaf A. Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 92 (1995) 3997-4001
63. Kang J.X., and Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 91 (1994) 9886-9890
64. McLennan P.L., Abeywardena M.Y., and Charnock J.S. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol 63 (1985) 1411-1417
65. Hock C.E., Beck L.D., Bodine R.C., and Reibel D.K. Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion. Am J Physiol 259 (1990) H1518-H1526
66. Billman G.E., Hallaq H., and Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 91 (1994) 4427-4430
67. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274 (1995) 1363-1367
68. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., and Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 93 (1996) 12559-12563
69. Young C., Gean P.W., Chiou L.C., and Shen Y.Z. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 37 (2000) 90-94
70. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., and Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19 (2000) 1784-1793
71. Xiao Y., and Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 846 (1999) 112-121
72. Yehuda S., Carasso R.L., and Mostofsky D.I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 254 (1994) 193-198
73. Rabinovitz S., Mostofsky D.I., and Yehuda S. Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology 29 (2004) 113-124
74. Schlanger S., Shinitzky M., and Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43 (2002) 103-104
75. Yuen A.W., Sander J.W., Fluegel D., et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 7 (2005) 253-258
76. Bromfield E., Dworetzky B., Hurwitz S., et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 12 (2008) 187-190